DHA

Dha is a lipid of Fatty Acyls (FA) class. Dha is associated with abnormalities such as Atherosclerosis, Consumption-archaic term for TB, Chronic disease, Cardiovascular Diseases and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as Inflammation, Oxidation, fatty acid oxidation, Fatty Acid Metabolism and Lipid Metabolism. Dha often locates in Hepatic, Protoplasm, Mucous Membrane, Epithelium and outer membrane. The associated genes with DHA are IMPACT gene, FATE1 gene, GAPDH gene, THOC4 gene and SLC33A1 gene. The related lipids are stearidonic acid, Fatty Acids, Total cholesterol, Lipopolysaccharides and Dietary Fatty Acid. The related experimental models are Mouse Model, Transgenic Model, Animal Disease Models and Arthritis, Experimental.

Cross Reference

Introduction

To understand associated biological information of DHA, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with DHA?

DHA is suspected in Cardiovascular Diseases, Obesity, Ischemia, Hypertensive disease, Coronary Arteriosclerosis, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with DHA

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Pain D010146 64 associated lipids
Per page 10 20 50 100 | Total 240

PubChem Associated disorders and diseases

What pathways are associated with DHA

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with DHA?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with DHA?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with DHA?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with DHA?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with DHA?

Mouse Model

Mouse Model are used in the study 'Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture.' (Bazan NG, 2007), Mouse Model are used in the study 'Omega-3 fatty acids EPA and DHA: health benefits throughout life.' (Swanson D et al., 2012), Mouse Model are used in the study 'Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.' (Depner CM et al., 2013) and Mouse Model are used in the study 'Wax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in mice.' (Höper AC et al., 2014).

Transgenic Model

Transgenic Model are used in the study 'Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging.' (Ma QL et al., 2014).

Animal Disease Models

Animal Disease Models are used in the study 'Fish oil increases muscle protein mass and modulates Akt/FOXO, TLR4, and NOD signaling in weanling piglets after lipopolysaccharide challenge.' (Liu Y et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with DHA

Download all related citations
Per page 10 20 50 100 | Total 7336
Authors Title Published Journal PubMed Link
Yeh YY et al. Modification of milk formula to enhance accretion of long-chain n-6 and n-3 polyunsaturated fatty acids in artificially reared infant rats. 1998 Lipids pmid:9625599
Almallah YZ et al. Distal procto-colitis, natural cytotoxicity, and essential fatty acids. 1998 Am. J. Gastroenterol. pmid:9625132
Lu CY et al. Docosahexaenoic acid, a constituent of fetal and neonatal serum, inhibits nitric oxide production by murine macrophages stimulated by IFN gamma plus LPS, or by IFN gamma plus Listeria monocytogenes. 1998 J. Reprod. Immunol. pmid:9616876
Ikeda I et al. Effects of dietary alpha-linolenic, eicosapentaenoic and docosahexaenoic acids on hepatic lipogenesis and beta-oxidation in rats. 1998 Biosci. Biotechnol. Biochem. pmid:9614698
Christensen MM et al. Dietary structured triacylglycerols containing docosahexaenoic acid given from birth affect visual and auditory performance and tissue fatty acid profiles of rats. 1998 J. Nutr. pmid:9614162
Kikuchi S et al. Modulation of eosinophil chemotactic activities to leukotriene B4 by n-3 polyunsaturated fatty acids. 1998 Prostaglandins Leukot. Essent. Fatty Acids pmid:9610849
Glozman S et al. Intraamniotic ethyl docosahexaenoate administration protects fetal rat brain from ischemic stress. 1998 J. Neurochem. pmid:9603213
Roberts LJ et al. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. 1998 J. Biol. Chem. pmid:9593698
Hossain MS et al. Influence of docosahexaenoic acid on cerebral lipid peroxide level in aged rats with and without hypercholesterolemia. 1998 Neurosci. Lett. pmid:9593513
Tashiro T et al. Effects of a newly developed fat emulsion containing eicosapentaenoic acid and docosahexaenoic acid on fatty acid profiles in rats. 1998 Nutrition pmid:9591310
Habán P et al. [The effect of n-3 fatty acid administration on selected indicators of cardiovascular disease risk in patients with type 2 diabetes mellitus]. 1998 Bratisl Lek Listy pmid:9588078
Hirafuji M et al. Effect of docosahexaenoic acid on smooth muscle cell functions. 1998 Life Sci. pmid:9585158
Green P and Yavin E Mechanisms of docosahexaenoic acid accretion in the fetal brain. 1998 J. Neurosci. Res. pmid:9579403
Zerouga M et al. Can docosahexaenoic acid inhibit metastasis by decreasing deformability of the tumor cell plasma membrane? 1997 Cancer Lett. pmid:9570367
Horie T et al. Docosahexaenoic acid exhibits a potent protection of small intestine from methotrexate-induced damage in mice. 1998 Life Sci. pmid:9566775
Nøding R et al. Effects of polyunsaturated fatty acids and their n-6 hydroperoxides on growth of five malignant cell lines and the significance of culture media. 1998 Lipids pmid:9560803
Nabekura J et al. Functional modulation of human recombinant gamma-aminobutyric acid type A receptor by docosahexaenoic acid. 1998 J. Biol. Chem. pmid:9556589
Bechoua S et al. Docosahexaenoic acid lowers phosphatidate level in human activated lymphocytes despite phospholipase D activation. 1998 J. Lipid Res. pmid:9555950
Kishida E et al. Distinctive inhibitory activity of docosahexaenoic acid against sphingosine-induced apoptosis. 1998 Biochim. Biophys. Acta pmid:9555103
Timmer-Bosscha H et al. Differential effects of all-trans-retinoic acid, docosahexaenoic acid, and hexadecylphosphocholine on cisplatin-induced cytotoxicity and apoptosis in a cisplantin-sensitive and resistant human embryonal carcinoma cell line. 1998 Cancer Chemother. Pharmacol. pmid:9554591
Hørby Jørgensen M et al. Effect of formula supplemented with docosahexaenoic acid and gamma-linolenic acid on fatty acid status and visual acuity in term infants. 1998 J. Pediatr. Gastroenterol. Nutr. pmid:9552137
Madsen L et al. Docosahexaenoic and eicosapentaenoic acids are differently metabolized in rat liver during mitochondria and peroxisome proliferation. 1998 J. Lipid Res. pmid:9548590
Sebaldt RJ and Marignani P Diradylglycerol formation is altered by n-3 highly unsaturated fatty acids, with differences between eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids. 1997 Adv. Exp. Med. Biol. pmid:9547650
Rousseau D et al. Is a dietary n-3 fatty acid supplement able to influence the cardiac effect of the psychological stress? 1998 Mol. Cell. Biochem. pmid:9546620
Voskuyl RA et al. Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model. 1998 Eur. J. Pharmacol. pmid:9543232
Starkopf J et al. Lipid peroxidation, arachidonic acid and products of the lipoxygenase pathway in ischaemic preconditioning of rat heart. 1998 Cardiovasc. Res. pmid:9539859
Wolk A et al. Effect of additional questions about fat on the validity of fat estimates from a food frequency questionnaire. Study Group of MRS SWEA. 1998 Eur J Clin Nutr pmid:9537304
Rhodes LE and White SI Dietary fish oil as a photoprotective agent in hydroa vacciniforme. 1998 Br. J. Dermatol. pmid:9536243
Paulsen JE et al. A fish oil-derived concentrate enriched in eicosapentaenoic and docosahexaenoic acid as ethyl esters inhibits the formation and growth of aberrant crypt foci in rat colon. 1998 Pharmacol. Toxicol. pmid:9527643
Urano S et al. Aging and oxidative stress in neurodegeneration. 1998 Biofactors pmid:9523034
Ramanadham S et al. Electrospray ionization mass spectrometric analyses of phospholipids from rat and human pancreatic islets and subcellular membranes: comparison to other tissues and implications for membrane fusion in insulin exocytosis. 1998 Biochemistry pmid:9521776
Ward PE et al. Niacin skin flush in schizophrenia: a preliminary report. 1998 Schizophr. Res. pmid:9516668
Larsen LN et al. Alpha- and beta- alkyl-substituted eicosapentaenoic acids: incorporation into phospholipids and effects on prostaglandin H synthase and 5-lipoxygenase. 1998 Biochem. Pharmacol. pmid:9514074
Osmundsen H et al. Effects of dietary treatment of rats with eicosapentaenoic acid or docosahexaenoic acid on hepatic lipid metabolism. 1998 Biochem. J. pmid:9512474
Conquer JA and Holub BJ Effect of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background. 1998 J. Lipid Res. pmid:9507989
Peterson LD et al. Eicosapentaenoic and docosahexaenoic acids alter rat spleen leukocyte fatty acid composition and prostaglandin E2 production but have different effects on lymphocyte functions and cell-mediated immunity. 1998 Lipids pmid:9507239
Hansen JB et al. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on fatty acid absorption, incorporation into serum phospholipids and postprandial triglyceridemia. 1998 Lipids pmid:9507234
Morita N and Shirai J Effects of microcapsulated docosahexaenoic acid preparation on properties of dough and bread. 1997 J. Nutr. Sci. Vitaminol. pmid:9505244
Woltil HA et al. Long-chain polyunsaturated fatty acid status and early growth of low birth weight infants. 1998 Eur. J. Pediatr. pmid:9504790
Hirafuji M et al. [Specific modulation of vascular smooth muscle cell functions by docosahexaenoic acid]. 1997 Nippon Yakurigaku Zasshi pmid:9503427
Alessandri JM et al. Docosahexaenoic acid concentrations in retinal phospholipids of piglets fed an infant formula enriched with long-chain polyunsaturated fatty acids: effects of egg phospholipids and fish oils with different ratios of eicosapentaenoic acid to docosahexaenoic acid. 1998 Am. J. Clin. Nutr. pmid:9497179
Calviello G et al. Dietary supplementation with eicosapentaenoic and docosahexaenoic acid inhibits growth of Morris hepatocarcinoma 3924A in rats: effects on proliferation and apoptosis. 1998 Int. J. Cancer pmid:9495237
Ramesh G and Das UN Effect of cis-unsaturated fatty acids on Meth-A ascitic tumour cells in vitro and in vivo. 1998 Cancer Lett. pmid:9489490
Nieuwenhuys CM and Hornstra G The effects of purified eicosapentaenoic and docosahexaenoic acids on arterial thrombosis tendency and platelet function in rats. 1998 Biochim. Biophys. Acta pmid:9487152
Prasad MR et al. Regional membrane phospholipid alterations in Alzheimer's disease. 1998 Neurochem. Res. pmid:9482271
Das UN et al. Can tumour cell drug resistance be reversed by essential fatty acids and their metabolites? 1998 Prostaglandins Leukot. Essent. Fatty Acids pmid:9482165
Mani I et al. Upregulation of nuclear PKC and MAP-kinase during hyperproliferation of guinea pig epidermis: modulation by 13-(S)-hydroxyoctadecadienoic acid (13-HODE). 1998 Cell. Signal. pmid:9481490
Germain E et al. Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: relationship to lipid peroxidation. 1998 Int. J. Cancer pmid:9466659
Yamane M et al. Docosahexaenoic/arachidonic acid omega-hydroxylation system and differentiation in the human colonic adenocarcinoma cell line, Caco-2. 1998 Cancer Lett. pmid:9464491
Zheng Z et al. Effect of ganglioside GM1 on ethanol-induced changes in the incorporation of free fatty acids into membrane phospholipids in mouse brain. 1997 Nov-Dec Alcohol Alcohol. pmid:9463723